{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:51:16Z","timestamp":1780671076584,"version":"3.54.1"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Mycosis fungoides (MF) is an indolent T-cell lymphoma that mainly affects the skin and presents with itch in more than half of the patients. Recently, the expression of Mas-related G protein-coupled receptor X2 (MRGPRX2), a receptor of mast cell (MC) responsible for the IgE-independent non-histaminergic itch, has been shown in lesional skin of patients with pruritic skin diseases, including chronic urticaria, prurigo, and mastocytosis. As of yet, limited knowledge exists regarding the MRGPRX2 expression in the skin of patients with MF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To investigate the number of MRGPRX2-expressing (MRGPRX2+) cells in the skin of patients with MF and its correlation with clinical and laboratory characteristics of the disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>MRGPRX2 was analyzed in lesional and non-lesional skin of MF patients and healthy skin tissues by immunohistochemistry. Co-localization of MRGPRX2 with the MC marker tryptase was assessed by immunofluorescence. Public single-cell RNAseq data was reanalyzed to identify the MRGPRX2 expression on the distinct cell types.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In lesional skin of MF patients, MRGPRX2+ cell number was higher than in non-lesional skin and healthy control skin (mean:15.12 vs. 6.84 vs. 5.51 cells\/mm<jats:sup>2<\/jats:sup>, p=0.04), and correlated with MC numbers (r=0.73, p=0.02). MC was the primary cell type expressing MRGPRX2 in MF patients. The ratio of MRGPRX2+ MCs to MRGPRX2+ cells in lesional and non-lesional skin correlated with the severity of disease (r=0.71, p=0.02 and r=0.67, p=0.03, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our findings point to the role of MRGPRX2 and MC in the pathogenesis of MF that should be investigated in further studies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1197821","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:43:05Z","timestamp":1698658985000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["In the skin lesions of patients with mycosis fungoides, the number of MRGPRX2-expressing cells is increased and correlates with mast cell numbers"],"prefix":"10.3389","volume":"14","author":[{"given":"Man","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Pyatilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Altrichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caibin","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Terhorst-Molawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Ginter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Puhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Kolkhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1468-3083.2004.00937.x","article-title":"Clinicopathological spectrum of mycosis fungoides","volume":"18","author":"Kazakov","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-020-00809-w","article-title":"Mycosis fungoides and s\u00e9zary syndrome: updates and review of current therapy","volume":"22","author":"Kamijo","year":"2021","journal-title":"Curr Treat Options Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jdin.2022.07.007","article-title":"Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator","volume":"9","author":"Ottevanger","year":"2022","journal-title":"JAAD Int"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05188.x","article-title":"Prevalence and severity of pruritus in cutaneous T cell lymphoma","volume":"51","author":"Vij","year":"2012","journal-title":"Int J Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.930979","article-title":"Mast cells and tryptase are linked to itch and disease severity in mycosis fungoides: Results of a pilot study","volume":"13","author":"Terhorst-Molawi","year":"2022","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0789","article-title":"Pruritus in cutaneous T-cell lymphomas: frequent, often severe and difficult to treat","volume":"90","author":"Meyer","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.immuni.2019.03.013","article-title":"Activation of mast-cell-expressed mas-related G-protein-coupled receptors drives non-histaminergic itch","volume":"50","author":"Meixiong","year":"2019","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/exd.14222","article-title":"MRGPRX2 sensing of cationic compounds-A bridge between nociception and skin diseases","volume":"30","author":"Corbi\u00e8re","year":"2021","journal-title":"Exp Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.930945","article-title":"The number of MRGPRX2-expressing cells is increased in skin lesions of patients with indolent systemic mastocytosis, but is not linked to symptom severity","volume":"13","author":"Pyatilova","year":"2022","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1016\/j.jaip.2021.05.042","article-title":"Expression of MRGPRX2 in skin mast cells of patients with maculopapular cutaneous mastocytosis","volume":"9","author":"Deepak","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B11","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.jaci.2014.05.004","article-title":"Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria","volume":"134","author":"Fujisawa","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1016\/j.jaci.2022.02.021","article-title":"Mast cells, cortistatin, and its receptor, MRGPRX2, are linked to the pathogenesis of chronic prurigo","volume":"149","author":"Kolkhir","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-19-0148","article-title":"Single-cell lymphocyte heterogeneity in advanced cutaneous T-cell lymphoma skin tumors","volume":"25","author":"Gaydosik","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl4896","article-title":"The Tabula Sapiens: A multiple-organ, single-cell transcriptomic atlas of humans","volume":"376","author":"Jones","year":"2022","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03027","article-title":"Mas-related G protein-coupled receptor-X2 (MRGPRX2) in drug hypersensitivity reactions","volume":"9","author":"Porebski","year":"2018","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/all.14213","article-title":"The pseudoallergen receptor MRGPRX2 on peripheral blood basophils and eosinophils: Expression and function","volume":"75","author":"Wedi","year":"2020","journal-title":"Allergy"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2008.03.007","article-title":"The role of cortistatin in the human immune system","volume":"286","author":"van Hagen","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2097","article-title":"Absence of full-length neurokinin-1 receptor protein expression by cutaneous T cells: implications for substance P-mediated signaling in mycosis fungoides","volume":"95","author":"Tuzova","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105318","article-title":"Substance P serves as a balanced agonist for MRGPRX2 and a single tyrosine residue is required for \u03b2-arrestin recruitment and receptor internalization","volume":"22","author":"Chompunud Na Ayudhya","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2005.03.001","article-title":"Adaptive evolution of MRGX2, a human sensory neuron specific gene involved in nociception","volume":"352","author":"Yang","year":"2005","journal-title":"Gene"},{"key":"B21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.clml.2020.11.007","article-title":"Mycosis fungoides and its relationship to atopy, serum total igE, and eosinophil counts","volume":"21","author":"Vonderheid","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1197821\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:43:07Z","timestamp":1698658987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1197821\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":21,"alternative-id":["10.3389\/fimmu.2023.1197821"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1197821","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,30]]},"article-number":"1197821"}}